Local excision after neoadjuvant chemoradiation therapy in advanced rectal cancer: a national multicenter analysis - 29/09/13
Colorectal Cancer Study Group, Korean Society of Coloproctology
Abstract |
Background |
The aim of the current study was to evaluate the clinical availability of local excision (LE) for advanced rectal cancer without lymph node metastasis after neoadjuvant chemoradiation therapy (nCRT) in Korea.
Methods |
From June 2000 to October 2009, 40 patients with cT2-3N0M0 rectal cancer underwent nCRT followed by LE according to a retrospective multicenter analysis.
Results |
Of the 40 patients, 22 were men and 18 were women. Eighteen patients were cT2, and 22 patients were cT3. The median follow-up duration was 38 months. Three patients (7.5%) had morbidity after LE. Four patients (10%) had recurrence (local recurrence [1 patient] and systemic metastasis [3 patients]). The 3-year disease-free survival rate was 85.9%. Only pCR was a recurrence-related prognostic factor (P = .040).
Conclusions |
Although the current study was not a randomized controlled study, LE after nCRT in T2-3N0 rectal cancer patients appears to be a safe and effective treatment, especially in pCR patients.
Le texte complet de cet article est disponible en PDF.Keywords : Rectal cancer, Neoadjuvant chemoradiation therapy, Local excision
Plan
| Supported in part by the Korean Society of Coloproctology. |
|
| The authors declare no conflicts of interest. |
Vol 206 - N° 4
P. 482-487 - octobre 2013 Retour au numéro
Article précédent
- Predictors of microinvasion and its prognostic role in ductal carcinoma in situ
- Gloria R. Sue, Donald R. Lannin, Brigid Killelea, Anees B. Chagpar
- Resource-efficient mobilization programs in the intensive care unit: who stands to win?
- John W. Mah, Ilene Staff, David Fichandler, Karyn L. Butler
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?